Fortress Biotech Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio0.970.650.943.626.59
P/B Ratio-34.0034.391.421.101.53
Price/Tangible Book24.214.902.593.51
Enterprise Value Ratios
EV/Revenue0.600.310.373.185.34
Profitability & Returns
Return on Equity (ROE)-5.97%-1.55%-0.78%-0.76%
Return on Assets (ROA)-0.41%-0.37%-0.37%-0.31%-0.21%
Return on Capital Employed (ROCE)-1.41%-1.65%-1.22%-0.61%-0.34%
Leverage & Solvency Ratios
Debt/Equity-46.2055.822.590.330.45
Liquidity Ratios
Current Ratio1.271.381.803.435.14
Quick Ratio0.951.131.623.264.99
Efficiency Ratios
Asset Turnover0.370.370.220.190.16
Inventory Turnover6.3110.5913.7928.5769.62
Yield & Distribution Ratios
Earnings Yield-0.82%-1.11%-1.22%-0.26%-0.15%
FCF Yield-1.43%-2.35%-2.56%-0.49%-0.28%
Buyback Yield-1.56%-0.37%-0.09%-0.13%-0.32%